Product Information
PRAMIPEXOLE ER 2.25 MG TABLET is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $1.3487 per EA under NDC 50742033430. Its NADAC has been published 179 times since Mar 22, 2023.
FDA first approved this application on Feb 3, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.25 mg/1
Manufacturer
Ingenus Pharmaceuticals LLCNDC
50742033430
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
PRAMIPEXOLE DIHYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213444FDA Approved
2/3/2022
TE Code
AB
On Market Since
3/10/2022
Pharmacological Classes
Price Statistics
The NADAC for PRAMIPEXOLE ER 2.25 MG TABLET has been published 179 times since Mar 22, 2023, and over the history we have for it it has declined 77.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.3487 per EA |
|---|---|
| All-time high | $6.0474 (Apr 10, 2024) |
| All-time low | $1.3487 (Aug 19, 2026) |
| 52-week high | $2.5034 |
| 52-week low | $1.3487 |
| Median price | $3.4538 |
| Average price | $3.8532 |
| Largest weekly change | -26.7% (Apr 17, 2024) |
| Weeks tracked | 179 |
| Tracking since | Mar 22, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Pramipexole dihydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PRAMIPEXOLE ER 2.25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PRAMIPEXOLE ER 2.25 MG TABLET, manufactured by Ingenus Pharmaceuticals LLC, is $1.3487 per EA (NDC 50742033430), effective Aug 19, 2026.
How has the price of PRAMIPEXOLE ER 2.25 MG TABLET changed over time?
Over the history we have for it, the NADAC for PRAMIPEXOLE ER 2.25 MG TABLET has declined 77.7%. It has been tracked across 179 weekly CMS publications since Mar 22, 2023.
What are the highest and lowest recorded NADAC prices for PRAMIPEXOLE ER 2.25 MG TABLET?
Since Mar 22, 2023, the NADAC for PRAMIPEXOLE ER 2.25 MG TABLET has ranged from a low of $1.3487 (Aug 19, 2026) to a high of $6.0474 (Apr 10, 2024), with a median of $3.4538 per EA.
Are there cheaper alternatives to PRAMIPEXOLE ER 2.25 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of PRAMIPEXOLE ER 2.25 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PRAMIPEXOLE ER 2.25 MG TABLET?
PRAMIPEXOLE ER 2.25 MG TABLET (NDC 50742033430) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.